Overview

Efficacy and Safety of Prurisol Administered Orally for Active Mild to Moderate Chronic Plaque Psoriasis

Status:
Completed
Trial end date:
2016-05-01
Target enrollment:
Participant gender:
Summary
This study is designed to evaluate the efficacy and safety of Prurisol using three different oral daily dose regimens administered to subjects with active mild to moderate chronic plaque psoriasis.
Phase:
Phase 2
Details
Lead Sponsor:
Cellceutix Corporation